{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:20:04Z","timestamp":1778750404393,"version":"3.51.4"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Post-COVID syndrome represents a major global health challenge which is characterized by immune dysregulation, although many aspects of the immune response remain incompletely understood, particularly the antibody response and the role of the complement system. We previously studied a post-COVID syndrome cohort in comparison to a COVID-recovered control cohort from Comunidad de Madrid (Spain) and found that post-COVID syndrome patients exhibited readily detectable serum anti-Nucleocapsid antibodies while showing deficient antibody production against the full-length Spike, despite maintaining a well-preserved anti-receptor binding domain (RBD) response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present study, we quantified anti-Nucleocapsid secretory immunoglobulin A (sIgA) in saliva and analyzed selected key components of the complement system, including C3, C4, factor B (FB), factor H (FH), and total hemolytic activity (CH50). Additionally, we quantified circulating immune complexes. We conducted general, stratified, correlation, and regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Anti-Nucleocapsid sIgA was increased in post-COVID syndrome samples compared with COVID-recovered controls. Although CH50 levels were similar, we detected a reduced concentration of C3. The levels of C4 were decreased but not significantly. Interestingly, in recently reinfected fully vaccinated patients, serum anti-Nucleocapsid IgG showed a negative correlation with FH and CH50. No differences were found for the concentration of circulating immune complexes. Regression analysis indicated that C3 levels can discriminate patients from controls efficiently, and combining anti- Nucleocapsid sIgA and C3 levels yielded improved discriminatory power.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The elevated anti-Nucleocapsid sIgA levels found did not correlate with increased anti-Nucleocapsid IgG in serum, as expected from their different temporal dynamics. The reduced C3 levels may reflect ongoing complement activation and subsequent consumption, which might be potentiated by increments in serum of anti-Nucleocapsid antibodies produced after reinfections. In conclusion, our findings suggest that salivary anti-Nucleocapsid IgA and C3 consumption, which seems to be more subtle parameter than CH50, may serve as candidate biomarkers of post-COVID syndrome, requiring validation in independent cohorts. Furthermore, these results implicate the complement system as a key dysregulated component of the immune response contributing to the pathophysiology of post-COVID syndrome, thus potentially amenable to targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1822171","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:54:56Z","timestamp":1778748896000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased anti-nucleocapsid secretory IgA and consumption of complement component 3 in post-COVID syndrome patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhiwen","family":"Hai","sequence":"first","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Ghazi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology & Area of Infectious Diseases and AIDS, Research Institute Hospital 12 de Octubre (imas12)","place":["Madrid, Spain"]},{"name":"Universidad Complutense de Madrid, Ciudad Universitaria","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Buitrago","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology & Area of Infectious Diseases and AIDS, Research Institute Hospital 12 de Octubre (imas12)","place":["Madrid, Spain"]},{"name":"Universidad Complutense de Madrid, Ciudad Universitaria","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mar\u00edn-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Immunology section, Fac. de CC. de la Salud, Departamento de Especialidades M\u00e9dicas y Salud P\u00fablica, Universidad Rey Juan Carlos (URJC)","place":["Alcorc\u00f3n, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel G","family":"Azc\u00e1rate","sequence":"additional","affiliation":[{"name":"Microbiology section, Fac. de CC. de la Salud, Departamento de Especialidades M\u00e9dicas y Salud P\u00fablica, Universidad Rey Juan Carlos (URJC)","place":["Alcorc\u00f3n, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Gonz\u00e1lez-Escalada","sequence":"additional","affiliation":[{"name":"Microbiology section, Fac. de CC. de la Salud, Departamento de Especialidades M\u00e9dicas y Salud P\u00fablica, Universidad Rey Juan Carlos (URJC)","place":["Alcorc\u00f3n, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nineth","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ben\u00edtez-Cruz","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Est\u00e9vez-Benito","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]},{"name":"Research Institute Hospital 12 de Octubre (imas12)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Tortajada","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]},{"name":"Research Institute Hospital 12 de Octubre (imas12)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Regueiro","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]},{"name":"Research Institute Hospital 12 de Octubre (imas12)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Bautista","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology & Area of Infectious Diseases and AIDS, Research Institute Hospital 12 de Octubre (imas12)","place":["Madrid, Spain"]},{"name":"Universidad Complutense de Madrid, Ciudad Universitaria","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narcisa","family":"Martinez-Quiles","sequence":"additional","affiliation":[{"name":"Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Universidad Complutense de Madrid, Avda de la Complutense","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.08.019","article-title":"Post-COVID or long-COVID: two different conditions or the same","volume":"14","author":"Mumoli","year":"2021","journal-title":"J Infect Public Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1186\/s12889-024-19264-5","article-title":"Post-COVID syndrome prevalence: a systematic review and meta-analysis","volume":"24","author":"Sk Abd Razak","year":"2024","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/path.6443","article-title":"Post-COVID-19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies","volume":"266","author":"Vlaming-van Eijk","year":"2025","journal-title":"J Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41590-025-02353-x","article-title":"Long COVID involves activation of proinflammatory and immune exhaustion pathways","volume":"27","author":"Aid","year":"2026","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01795-z","article-title":"Immune dysregulation in long COVID","volume":"25","author":"Ceglarek","year":"2024","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.782421","article-title":"Respiratory mucosal immunity: kinetics of secretory immunoglobulin A in sputum and throat swabs from COVID-19 patients and vaccine recipients","volume":"13","author":"Ren","year":"2022","journal-title":"Front Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70645","article-title":"Detection of anti-SARS-CoV-2 mucosal immunoglobulin A in clinical saliva samples after a dose of Novavax COVID-19 vaccine","volume":"97","author":"Zhu","year":"2025","journal-title":"J Med Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.751705","article-title":"Multiplex antibody analysis of IgM, IgA and IgG to SARS-CoV-2 in saliva and serum from infected children and their close contacts","volume":"13","author":"Dobano","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17952","article-title":"SARS-CoV-2 antibody levels and long COVID occurrence in blood donors","volume":"64","author":"Avelino-Silva","year":"2024","journal-title":"Transfusion"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1670324","article-title":"Post-COVID syndrome patients show reduced anti-Spike antibodies compared to COVID-recovered controls, but enhanced IgG4\/IgG1 switch after the third vaccine dose","volume":"16","author":"Rossi","year":"2025","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1038\/s41598-026-37866-4","article-title":"SARS-CoV-2 nucleocapsid protein forms complexes with soluble complement regulatory proteins that can bind to the virion","volume":"16","author":"Viglasky","year":"2026","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100995","article-title":"Complement activation in COVID-19 and targeted therapeutic options: a scoping review","volume":"57","author":"Lim","year":"2023","journal-title":"Blood Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.767981","article-title":"SARS-CoV-2 antibodies mediate complement and cellular driven inflammation","volume":"12","author":"Jarlhelt","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156295","article-title":"Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition","volume":"169","author":"Garcia-Gasalla","year":"2023","journal-title":"Cytokine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.108032","article-title":"Classic pathway persistent complement activation is associated with specific symptoms in individuals with post-COVID-19 condition: a case-control study","volume":"159","author":"Fernandez-de-Las-Penas","year":"2025","journal-title":"Int J Infect Dis"},{"key":"B21","article-title":"Type III hypersensitivity reaction","volume-title":"StatPearls","author":"Saavedra Torres","year":"2025"},{"key":"B22","first-page":"79","article-title":"How to control confounding effects by statistical analysis","volume":"5","author":"Pourhoseingholi","year":"2012","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288557","article-title":"Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: a prospective longitudinal study","volume":"18","author":"Amellal","year":"2023","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.939989","article-title":"Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID","volume":"13","author":"Goh","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838780","article-title":"SARS-CoV-2 spike- and nucleoprotein-specific antibodies induced after vaccination or infection promote classical complement activation","volume":"13","author":"Lamerton","year":"2022","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115512","article-title":"Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition","volume":"44","author":"Fahoum","year":"2025","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/antib8040057","article-title":"IgA: structure, function, and developability","volume":"8","author":"de Sousa-Pereira","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13424","article-title":"Immunoglobulin A antibodies: from protection to harmful roles","volume":"328","author":"Gleeson","year":"2024","journal-title":"Immunol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105823","article-title":"Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses","volume":"223","author":"Sinha","year":"2024","journal-title":"Antiviral Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.655896","article-title":"IgA antibodies and IgA deficiency in SARS-CoV-2 infection","volume":"11","author":"Quinti","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/imr.13118","article-title":"Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection","volume":"309","author":"Sheikh-Mohamed","year":"2022","journal-title":"Immunol Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang","year":"2021","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.831744","article-title":"Long-term post-COVID-19 associated oral inflammatory sequelae","volume":"12","author":"Alfaifi","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274841","article-title":"Interleukin-17, a salivary biomarker for COVID-19 severity","volume":"17","author":"Sharif-Askari","year":"2022","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148435","article-title":"A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients","volume":"6","author":"Morrissey","year":"2021","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17958","article-title":"Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19","volume":"9","author":"Jang","year":"2023","journal-title":"Heliyon"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14110598","article-title":"Salivary metabolomics in patients with long COVID-19 infection","volume":"14","author":"MaChado","year":"2024","journal-title":"Metabolites"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/v16111769","article-title":"Longitudinal (1)H NMR-based metabolomics in saliva unveils signatures of transition from acute to post-acute phase of SARS-CoV-2 infection","volume":"16","author":"Mendes","year":"2024","journal-title":"Viruses"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.70029","article-title":"Oral SARS-CoV-2 infection and risk for long Covid","volume":"35","author":"Schwartz","year":"2025","journal-title":"Rev Med Virol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s43856-023-00264-2","article-title":"Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults","volume":"3","author":"Thomas","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1613195","article-title":"Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in long COVID","volume":"16","author":"Simon-Rueda","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1038\/s41467-025-58766-7","article-title":"Anti-nucleocapsid and anti-spike antibody trajectories in people with post-covid condition versus acute-only infections: a nested longitudinal case-control study within the Virus Watch prospective cohort","volume":"16","author":"Beale","year":"2025","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2023.11.007","article-title":"Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: a study of 290 convalescent COVID-19 patients","volume":"17","author":"Ellis","year":"2024","journal-title":"Mucosal Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01724-6","article-title":"Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2","volume":"25","author":"Yin","year":"2024","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.194314","article-title":"The role of complement in long COVID pathogenesis","volume":"10","author":"Bayarri-Olmos","year":"2025","journal-title":"JCI Insight"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14020439","article-title":"Complement system dysregulation in the immunopathogenesis of long COVID: systematic evidence synthesis","volume":"14","author":"Notarte","year":"2026","journal-title":"Biomedicines"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.01.014","article-title":"Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis","volume":"28","author":"Alkodaymi","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2196\/72221","article-title":"Symptom trajectories and clinical subtypes in post-COVID-19 condition: systematic review and clustering analysis","volume":"11","author":"Hu","year":"2025","journal-title":"JMIR Public Health Surveill"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/all.15471","article-title":"Association between Epstein-Barr-virus reactivation and development of long-covid fatigue","volume":"78","author":"Rohrhofer","year":"2023","journal-title":"Allergy"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696085","article-title":"Serum complement C3 and C4 and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression","volume":"12","author":"Zinellu","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/imm.70110","article-title":"Activation of the lectin pathway drives persistent complement dysregulation in long COVID","volume":"178","author":"Keat","year":"2026","journal-title":"Immunology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1162171","article-title":"Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups","volume":"14","author":"Hurler","year":"2023","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imbio.2009.08.006","article-title":"Paths reunited: initiation of the classical and lectin pathways of complement activation","volume":"215","author":"Wallis","year":"2010","journal-title":"Immunobiology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076990","article-title":"Covid-19 vaccine effectiveness against post-covid-19 condition among 589\u2013722 individuals in Sweden: population based cohort study","volume":"383","author":"Lundberg-Morris","year":"2023","journal-title":"BMJ"},{"key":"B57","doi-asserted-by":"publisher","first-page":"36951","DOI":"10.1038\/s41598-025-20926-6","article-title":"In vitro complement activation via nucleocapsid and spike proteins of SARS-CoV-2 in COVID-19 patients","volume":"15","author":"Kiszel","year":"2025","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1162804\/v1","article-title":"Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity","volume":"8","author":"Lopez-Munoz","year":"2022","journal-title":"Sci Adv"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.1c00010","article-title":"Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2","volume":"7","author":"Liu","year":"2021","journal-title":"ACS Cent Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1822171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:54:57Z","timestamp":1778748897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1822171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2026.1822171"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1822171","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"1822171"}}